Try our beta test site
252 studies found for:    Open Studies | "Colitis"
Show Display Options
Rank Status Study
21 Recruiting Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission
Condition: Colitis, Ulcerative
Intervention: Drug: Golimumab
22 Recruiting TD-1473 for Active Ulcerative Colitis (UC)
Conditions: Ulcerative Colitis, Active Moderate;   Ulcerative Colitis, Active Severe
Interventions: Drug: TD-1473;   Drug: Placebo
23 Recruiting Linked Color Imaging vs. White Light for Colorectal Dysplasia in Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Device: Linked Color Imaging;   Device: white light imaging
24 Recruiting Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Other: Probiotics in the form of cheese portion
25 Not yet recruiting Ulcerative Colitis Relapse Prevention by Prebiotics
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Synergy-1;   Dietary Supplement: Maltodextrin
26 Not yet recruiting Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)
Condition: ULCERATIVE COLITIS
Interventions: Drug: VEDOLIZUMAB;   Drug: ADALIMUMAB
27 Recruiting Identification/Characterization of Changes in Microscopic Colitis
Condition: Colitis, Microscopic
Intervention:
28 Recruiting Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
29 Recruiting Comparison of PillCamCOLON (C2) Capsule and Standard Endoscopy for the Evaluation of Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Device: standard endoscopy;   Device: PillCamCOLON (C2)
30 Recruiting Thermography in Surveillance of Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Device: Thermography;   Procedure: Colonoscopy
31 Not yet recruiting A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Azathioprine;   Drug: Infliximab;   Drug: Prednisolone;   Drug: Hydrocortisone
32 Recruiting Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
Condition: Colitis, Ulcerative
Intervention: Other: No Intervention
33 Recruiting Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis
Condition: Moderate Active Ulcerative Colitis
Interventions: Drug: E6007;   Drug: Placebo
34 Recruiting An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
35 Recruiting Low Dose IL-2 for Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Interleukin-2 (aldesleukin).
36 Recruiting FMT in Ulcerative Colitis-Associated Pouchitis
Condition: Ulcerative Colitis Associated Pouchitis
Interventions: Biological: biologically active human fecal microbiota;   Procedure: sigmoidoscopy
37 Recruiting Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: UCMSC group;   Other: Control group(Normal saline)
38 Not yet recruiting The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
39 Recruiting A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Intervention:
40 Recruiting A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Interventions: Drug: LT-02;   Drug: LT-02 Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.